Literature DB >> 8206101

Preformed purified peptide/major histocompatibility class I complexes are potent stimulators of class I-restricted T cell hybridomas.

A Stryhn1, L O Pedersen, V Ortiz-Navarrete, S Buus.   

Abstract

A panel of antigen-specific, major histocompatibility complex class I-restricted T cell hybridomas has been generated to examine the capacity of peptide/class I complexes to stimulate T cells at the molecular level. Peptide/class I complexes were generated in detergent solution, purified and quantitated. Latex particles were subsequently coated with known amounts of preformed complexes and used to stimulate the T cell hybridomas. Stimulation was specific, i.e. only the appropriate peptide/class I combination were stimulatory, and quite sensitive, i.e. as little as 300 complexes per bead could be detected by the T cells. Preformed complexes were about 500,000 times more potent than free peptide in terms of T cell stimulation, demonstrating the physiological relevancy of the biochemically generated complexes. Surprisingly, the majority (including the most sensitive of the hybridomas) had lost CD8 expression, suggesting that antigen-specific stimulation of class I-restricted T cell hybridomas, as assessed by IL-2 release, does not depend on CD8.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206101     DOI: 10.1002/eji.1830240625

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.

Authors:  A Stryhn; P S Andersen; L O Pedersen; A Svejgaard; A Holm; C J Thorpe; L Fugger; S Buus; J Engberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

2.  A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

Authors:  P S Andersen; A Stryhn; B E Hansen; L Fugger; J Engberg; S Buus
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.

Authors:  Y Reiter; A Di Carlo; L Fugger; J Engberg; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 12.779

4.  T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides.

Authors:  S L Larsen; L O Pedersen; S Buus; A Stryhn
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.